Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Apodex is an advanced, self-evolving solver designed for in-depth research, focusing on providing answers that hold up to scrutiny through thorough reasoning rather than mere quick responses. It meticulously tackles complex problems in a step-by-step manner, ensuring that every conclusion is validated before progressing, and each report is accompanied by verified citations. Specifically created for intricate questions that lack straightforward answers, Apodex delves deeply into research, scrutinizes evidence, and confirms each step, allowing users to have confidence in the pathway leading to the final conclusion. Users with accounts have the capability to save their inquiries, revisit them later, continue their investigations at will, search within various threads, branch off from any report, and review the reasoning behind each step in detail. The Apodex-1.0 model emphasizes verification in deep research and can function as a conventional tool through the ReAct agent, while its robust mode operates a team of asynchronous agents that delegate tasks to specialized sub-agents for retrieval and verification, which then share findings through a collective evidence repository, ultimately feeding into a global verification system. This innovative approach not only enhances the reliability of research outcomes but also promotes an interactive and user-friendly experience for those seeking comprehensive answers.
Description
FN2 functions as an independent stock decision-making engine, designed to relieve you from the repetitive daily research tasks. Rather than engaging in the same research cycle each morning, FN2 employs AI agents that actively monitor the markets, conduct in-depth research according to a set schedule, and send their findings directly to your Inbox, Phone, or Discord.
You can express your tracking preferences in plain language, whether it's a specific ticker, a sector, a particular thesis, or a question like "notify me when NVDA's guidance changes," or you can select from a range of pre-configured agents. FN2 then transforms your input into an autonomous research agent that operates on your timeline—be it before market open, immediately following earnings reports, or on a weekly basis. Each agent meticulously analyzes earnings-call transcripts, retrieves macroeconomic data from FRED, evaluates tickers, creates visual charts, and synthesizes all this information to provide you with a decision-ready summary instead of just a collection of raw data. This means no more juggling multiple tabs, no reliance on screeners, and no need to conduct manual morning research. FN2 is specifically designed for dedicated individual investors and analysts who find themselves overwhelmed by the sheer volume of tabs, transcripts, and screeners resulting from repetitive daily tasks. By streamlining the research process, FN2 allows you to focus on making informed investment decisions with greater efficiency and ease.
API Access
Has API
API Access
Has API
Screenshots View All
No images available
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
$30/month
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Apodex
Founded
2025
Country
United States
Website
www.apodex.ai/
Vendor Details
Company Name
FN2
Founded
2026
Country
United States
Website
fn2.ai
Product Features
Product Features
Alternatives
No Alternatives